Zacks: Analysts Anticipate HCP, Inc. (HCP) Will Announce Earnings of $0.43 Per Share

Equities research analysts predict that HCP, Inc. (NYSE:HCP) will announce earnings of $0.43 per share for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for HCP’s earnings. The lowest EPS estimate is $0.42 and the highest is $0.44. HCP reported earnings per share of $0.48 in the same quarter last year, which suggests a negative year-over-year growth rate of 10.4%. The business is expected to announce its next quarterly earnings report on Tuesday, February 12th.

On average, analysts expect that HCP will report full year earnings of $1.82 per share for the current year, with EPS estimates ranging from $1.80 to $1.83. For the next financial year, analysts anticipate that the firm will post earnings of $1.77 per share, with EPS estimates ranging from $1.69 to $1.81. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for HCP.

HCP (NYSE:HCP) last issued its quarterly earnings results on Wednesday, October 31st. The real estate investment trust reported $0.21 EPS for the quarter, topping the Zacks’ consensus estimate of $0.11 by $0.10. The business had revenue of $456.00 million for the quarter, compared to analyst estimates of $456.59 million. HCP had a return on equity of 3.06% and a net margin of 9.16%. HCP’s quarterly revenue was up .4% compared to the same quarter last year. During the same period last year, the company posted $0.48 earnings per share.

Several brokerages have issued reports on HCP. Zacks Investment Research restated a “sell” rating on shares of HCP in a research note on Tuesday, November 13th. Morgan Stanley boosted their target price on HCP from $23.50 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, August 16th. Mizuho restated a “buy” rating and issued a $29.00 target price on shares of HCP in a research note on Monday, August 13th. Cantor Fitzgerald boosted their target price on HCP from $29.00 to $30.00 and gave the company an “overweight” rating in a research note on Thursday, November 1st. Finally, ValuEngine upgraded HCP from a “hold” rating to a “buy” rating in a research note on Monday, November 12th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $26.75.

In other news, COO Thomas Klaritch sold 82,532 shares of HCP stock in a transaction on Tuesday, December 4th. The stock was sold at an average price of $29.51, for a total value of $2,435,519.32. Following the completion of the transaction, the chief operating officer now directly owns 256,280 shares in the company, valued at $7,562,822.80. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.14% of the stock is currently owned by insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the company. First Midwest Bank Trust Division grew its position in shares of HCP by 20.6% in the third quarter. First Midwest Bank Trust Division now owns 34,617 shares of the real estate investment trust’s stock valued at $911,000 after purchasing an additional 5,922 shares in the last quarter. Cornerstone Wealth Management LLC grew its position in HCP by 17.6% during the third quarter. Cornerstone Wealth Management LLC now owns 46,336 shares of the real estate investment trust’s stock worth $1,727,000 after buying an additional 6,938 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in HCP by 51.3% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 240,759 shares of the real estate investment trust’s stock worth $6,216,000 after buying an additional 81,593 shares in the last quarter. Glen Harbor Capital Management LLC grew its position in HCP by 3.2% during the second quarter. Glen Harbor Capital Management LLC now owns 188,530 shares of the real estate investment trust’s stock worth $4,868,000 after buying an additional 5,848 shares in the last quarter. Finally, Swiss National Bank grew its position in HCP by 3.5% during the second quarter. Swiss National Bank now owns 1,552,121 shares of the real estate investment trust’s stock worth $40,076,000 after buying an additional 52,900 shares in the last quarter. Institutional investors own 90.00% of the company’s stock.

Shares of HCP traded down $0.36 during mid-day trading on Monday, hitting $29.87. The stock had a trading volume of 3,379,803 shares, compared to its average volume of 3,612,483. The firm has a market cap of $14.21 billion, a PE ratio of 15.32, a PEG ratio of 7.62 and a beta of 0.23. The company has a debt-to-equity ratio of 1.21, a current ratio of 0.48 and a quick ratio of 0.48. HCP has a 52 week low of $21.48 and a 52 week high of $30.26.

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 20th. Stockholders of record on Monday, November 5th were given a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 4.95%. The ex-dividend date of this dividend was Friday, November 2nd. HCP’s dividend payout ratio (DPR) is presently 75.90%.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

See Also: Debt-To-Equity Ratio

Get a free copy of the Zacks research report on HCP (HCP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply